Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Juneteenth
Artificial Intelligence
Donald Trump
War
Social Media
Stock Markets
Infrastructure
Education
Military
Natural Disasters
Property
World Cup
Pharmacy Times image

News from Pharmacy Times

We’ve assigned a rating of Unknown factuality to Pharmacy Times. You can read more about how we’ve determined Pharmacy Times’s credibility and reliability as a news source here: https://ground.news/rating-system.

Information about Pharmacy Times

Where is Pharmacy Times located?Pharmacy Times's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Pharmacy Times News

FDA Approves Once-Monthly Hereditary Angioedema Drug
FDA · United States

FDA Approves Once-Monthly Hereditary Angioedema Drug

62% Center coverage: 32 sources
Anti-factor XIIa biologic garadacimab (Andembry) got the FDA greenlight for use in preventing hereditary angioedema (HAE) attacks in adult and pediatric patients ages 12 years and older, CSL announced.See the Story
Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients
United States · United States

Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients

71% Center coverage: 32 sources
Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or psoriatic arthritis (PsA) under 60kgThe FDA previously approved STEQEYMA® 45mg/0.5mL, 90mg/mL in a single-dose prefilled syringe for subcutaneous…See the Story
Dupixent® (Dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic ...

Dupixent® (Dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic ...

100% Center coverage: 3 sources
New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpointsSee the Story

Prior Auth for Obesity Drugs; New Dietary Guidelines? Bariatric Surgery vs GLP-1s

Coverage: 2 sources
(MedPage Today) -- The American Medical Association's House of Delegates passed an Endocrine Society resolution that aims to improve access to weight-loss medications by reducing the burden of prior authorization. Patients on Eli Lilly's investigational...Diabetes · United StatesSee the Story

Impact of RSVpreF Vaccination on Reducing the Burden of Respiratory Syncytial Virus in Infants and Older Adults

100% Center coverage: 1 sources
Respiratory syncytial virus (RSV) causes a substantial health burden among infants and older adults. Prefusion F protein-based vaccines have shown high efficacy against RSV disease in clinical trials, offering promise for mitigating this burden through maternal and older adult immunization. Employing an individual-based model, we evaluated the impact of RSV vaccination on hospitalizations and deaths in 13 high-income countries, assuming that the…VaccinesSee the Story

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.Austin, Texas · AustinRead Article

Tom Kraus on Top Advocacy Priorities for Pharmacists: 340B Protections, Payment Reform, and Grassroots Action

From protecting the 340B Drug Pricing Program to expanding payment pathways through state-level reforms and Medicare Advantage opportunities, Kraus emphasized the critical role pharmacists play in evolving care models.United States · United StatesRead Article

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.Austin, Texas · AustinRead Article

Multi-Phenotype Approach Highlights Increased Power of cPCA When Identifying CKD-Related Loci

The authors note that the combinatorial principal component analysis (cPCA) may be effective in other complex diseases outside of chronic kidney disease (CKD).Read Article

Assessing Prescriber Justification for Use of Outpatient Chemotherapy in the Acute Care Setting

This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.HealthcareRead Article

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care – RamaOnHealthcare

Host Craig Beavers chats with Shannon Finks, PharmD, FCCP, BCPS, BCCP, AHSCP-CHC, president and director of pharmacy services at ZupMed in Memphis,Health Care · MemphisSee the Story

Breaking News Topics Related to Pharmacy Times

Health

Health

Cancer

Cancer

United States

United States

Medical

Medical

News
For You
SearchBlindspotLocal